search
radiation oncology
Trends
- 1Penn Medicine and IBA Launch Proton Therapy Joint Venture▼Penn Medicine, IBA Form Joint Venture to Advance Proton Therapy, Radiation Oncology
Penn Medicine and Belgian proton therapy firm IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will focus on developing and expanding access to advanced radiation treatments for cancer patients. Announced via trade press coverage in medical imaging and technology outlets, the collaboration is being watched for its potential impact on cancer care delivery.
- 2Mount Sinai to test novel liquid radioembolic agent for brain tumors●Mount Sinai announces collaborative research agreement to evaluate novel liquid radioembolic agent for brain tumors
Mount Sinai has announced a collaborative research agreement to evaluate a novel liquid radioembolic agent for treating brain tumors. The therapy would deliver radiation directly to tumor tissue in liquid form, an approach being explored for cancers that are difficult to treat surgically. Details on the partner institution, trial design and timeline have not yet been released, and clinical results remain pending.